Pages with the most revisions
Jump to navigation
Jump to search
Showing below up to 250 results in range #51 to #300.
View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)
- Absorbed fraction (5 revisions)
- Effective half-life (4 revisions)
- Averted dose (4 revisions)
- Kp index (4 revisions)
- Protective action (4 revisions)
- Reference Animal and Plant (4 revisions)
- Forbiddenness (4 revisions)
- Aerodynamic diameter (4 revisions)
- ICRP (4 revisions)
- Diagnostic reference level (4 revisions)
- Source-related assessment (4 revisions)
- Reference bioassay function (4 revisions)
- Risk (4 revisions)
- Senescence (4 revisions)
- Air-kerma, product (4 revisions)
- Fractionation sensitivity (4 revisions)
- Optimisation (4 revisions)
- Air kerma at the patient entrance reference point (4 revisions)
- High linear energy transfer radiation (4 revisions)
- Sievert (4 revisions)
- Non-maleficence (4 revisions)
- S coefficient (radiation weighted) (4 revisions)
- Bioassay (4 revisions)
- Calculating Radon Doses (4 revisions)
- Computed tomography dose index (4 revisions)
- Direct bioassay (4 revisions - redirect page)
- Alpha decay (4 revisions)
- Effective charge number (4 revisions)
- Mass median diameter (4 revisions)
- Math (4 revisions)
- Programmed cell death (4 revisions)
- Flexible tissues (3 revisions)
- Wisdom (3 revisions)
- Guide to the System of Radiological Protection (3 revisions)
- Autonomy (3 revisions)
- Dose limit (3 revisions)
- Dose limits (3 revisions)
- Target region (3 revisions)
- Fluence (3 revisions)
- Constancy test (3 revisions)
- Dose (3 revisions)
- Fluoroscopically guided interventions (3 revisions)
- Annual dose (3 revisions)
- DS02 (3 revisions)
- Dose of record (E) (3 revisions)
- Accountability (3 revisions)
- Half-life, physical (3 revisions)
- Potential exposure (3 revisions)
- Cell death (3 revisions)
- Contamination (3 revisions)
- Low Earth orbit (3 revisions)
- Exponential survival curve (3 revisions)
- X ray (3 revisions)
- Annual limit on intake (3 revisions)
- Rigidity threshold (3 revisions)
- Dose per content function (3 revisions)
- Equity (3 revisions)
- Unsealed source (3 revisions)
- Xerostomia (3 revisions)
- Graded approach (3 revisions)
- Interphase death (3 revisions)
- Test (3 revisions)
- Fractionation (3 revisions)
- Public exposure (3 revisions)
- Uptake (3 revisions)
- Active (red) bone marrow (3 revisions)
- Granulocyte-macrophage colony-stimulating factor (3 revisions)
- Utilitarian ethics (3 revisions)
- Operational quantity (3 revisions)
- Granulocyte colony-stimulating factor (3 revisions)
- Coster-Kronig transition (3 revisions)
- Emergency preparedness (3 revisions)
- Value judgement (3 revisions)
- Gray (3 revisions)
- Emergency procedures (3 revisions)
- Absolute risk (3 revisions)
- Valvular heart disease (3 revisions)
- Personal dose equivalent (3 revisions)
- Auger transition (3 revisions)
- Principle of justification (3 revisions)
- Bystander effect (3 revisions)
- Radiofrequency ablation (3 revisions)
- Iso-effect plots (3 revisions)
- Lifetime risk estimates (3 revisions)
- Employer (3 revisions)
- Virtue ethics (3 revisions)
- Activity median thermodynamic diameter (3 revisions)
- Complex tissues (3 revisions)
- Derived air concentration (3 revisions)
- Dignity (3 revisions)
- Isomers (3 revisions)
- Voxel phantom (3 revisions)
- Growth fraction (3 revisions)
- Radiological Protection in Healthcare (3 revisions - redirect page)
- Excretion rate (instantaneous) (3 revisions)
- Extrathoracic airways (3 revisions)
- Galactic cosmic radiation (3 revisions)
- Organ dose equivalent (3 revisions)
- Growth hormone (somatotropin) (3 revisions)
- ICRP Publication 103 (3 revisions)
- Fairness (3 revisions)
- Absorption (3 revisions)
- Gamma ray (3 revisions)
- DNA damage signalling (3 revisions)
- Spread-out Bragg peak (3 revisions)
- Field-size effect (Volume effect) (3 revisions)
- Gastrointestinal syndrome (3 revisions)
- Biomedical research volunteer (3 revisions)
- Cardiomyopathy (3 revisions)
- Recovery (3 revisions)
- Dose equivalent (3 revisions)
- Stakeholder (2 revisions)
- Effective dose equivalent (2 revisions)
- Tachycardia (2 revisions)
- Tissue equivalent material (2 revisions)
- Existing exposure situation (2 revisions)
- Myocardial stress test (2 revisions)
- Gastroschisis (2 revisions)
- Oversight (2 revisions)
- Angiogenesis (2 revisions)
- Hyperbaric oxygen (2 revisions)
- Projected dose (2 revisions)
- Bioturbation (2 revisions)
- Cardioverter-defibrillator (2 revisions)
- Radionuclides of natural origin (2 revisions)
- Recovery (cellular or tissue) (2 revisions)
- Consequential late effects (2 revisions)
- Retrievability (2 revisions)
- Immune system (2 revisions)
- Institutional control (2 revisions)
- Epithelium (2 revisions)
- Acceptance test (2 revisions)
- Worker (2 revisions)
- Nuclear track detectors (2 revisions)
- Gastrulation (2 revisions)
- Habitual mouth breather (2 revisions)
- Annihilation photons (2 revisions)
- Hyperfractionation (2 revisions)
- Bone marrow (2 revisions)
- Radiation safety officer (2 revisions)
- Radioresponsiveness (2 revisions)
- Cohort study (2 revisions)
- Recovery responder (2 revisions)
- DRL value (2 revisions)
- Reversibility (2 revisions)
- In vivo radiobioassay (2 revisions)
- Solar particle event (2 revisions)
- Target tissue (2 revisions)
- Equieffective dose (2 revisions)
- Measuring and Reducing Radon Levels in your Home (2 revisions)
- Expanded and aligned radiation field (2 revisions)
- Working level (2 revisions)
- OLINDA/EXM (2 revisions)
- Adventitious (2 revisions)
- Particle radiance (2 revisions)
- Habitual nose breather (2 revisions)
- Hypertrophic cardiomyopathy (2 revisions)
- Background dose (rate) (2 revisions)
- Protection strategy (2 revisions)
- Radiation source (2 revisions)
- Radiosensitiser (2 revisions)
- Containment (2 revisions)
- Rehabilitation of living conditions (2 revisions)
- Right to know (2 revisions)
- Incidence (2 revisions)
- Dose-length product (2 revisions)
- Solar wind (2 revisions)
- Stenosis (2 revisions)
- Electron-capture decay (2 revisions)
- Local DRL (2 revisions)
- Tolerability (2 revisions)
- Medical exposure (2 revisions)
- Naturally occurring radioactive material (2 revisions)
- Fluoroscopically or computed tomography guided interventions (2 revisions)
- Working level month (2 revisions)
- Hypoplasia (2 revisions)
- Backscatter detection system (2 revisions)
- Bradycardia (2 revisions)
- Radiosensitivity, cellular (2 revisions)
- Rigidity (2 revisions)
- Detriment (2 revisions)
- Security (2 revisions)
- Incident (2 revisions)
- Dose-rate effect (2 revisions)
- Intermediate level waste (2 revisions)
- Dose of record Hp (10) (2 revisions)
- LD 50/30 (2 revisions)
- Electrophysiology (2 revisions)
- Telangiectasia (2 revisions)
- Member of the public (2 revisions)
- Unattached fraction (2 revisions)
- Necrosis (2 revisions)
- Accreditation (2 revisions)
- Genomic integrity (2 revisions)
- Patient entrance reference point (2 revisions)
- Hazard (2 revisions)
- Potential recoverability correction factor (2 revisions)
- Protective action guide (2 revisions)
- Bragg peak (2 revisions)
- Radiation worker (2 revisions)
- Coronary heart disease (2 revisions)
- Decay constant (2 revisions)
- Inclusiveness (2 revisions)
- Source-related (2 revisions)
- Internal conversion electron (2 revisions)
- Storage (2 revisions)
- Track structure (2 revisions)
- Mendelian diseases (2 revisions)
- Neurological syndrome (2 revisions)
- Fractional absorption in the gastrointestinal tract (2 revisions)
- Action Level (2 revisions)
- Occupational exposure (2 revisions)
- Peak skin dose (2 revisions)
- Health Surveillance (2 revisions)
- Basal cell (2 revisions)
- Branching fraction (2 revisions)
- Radioactive dispersion device (2 revisions)
- Chronic exposure (2 revisions)
- Radon: Units of Measure (2 revisions)
- Colony (2 revisions)
- Reference air kerma (2 revisions)
- Cosmic Radiation in Aviation (2 revisions)
- Decommissioning (2 revisions)
- Self-help protection (2 revisions)
- Individual-related (2 revisions)
- Dose-threshold (2 revisions)
- Dose per unit intake coefficient (2 revisions)
- Subcutaneous tissue (2 revisions)
- Emergency (2 revisions)
- Low dose rate (2 revisions)
- Transfer compartment (2 revisions)
- Mitigation (2 revisions)
- Exposure, external or internal (2 revisions)
- Upper reference levels (2 revisions)
- Neurovascular syndrome (2 revisions)
- Graft vs host disease (2 revisions)
- Air-kerma, incident (2 revisions)
- Pelagic (2 revisions)
- Heliosphere (2 revisions)
- Practical radiological protection culture (2 revisions)
- Radioactive source (2 revisions)
- Class SR-0 gases (2 revisions)
- Decontamination (2 revisions)
- ICRP Task Groups on Radiological Protection in Healthcare (2 revisions)
- Diastasis (2 revisions)
- Individual decontamination (2 revisions)
- Source term (2 revisions)
- Dose rate (2 revisions)
- Latent time/period or latency interval (2 revisions)
- Emergency exposure situation (2 revisions)
